The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation
Open accessAbstract
The emerging potential for the cannabinoid (CB) system in modulating gastrointestinal inflammation has gained momentum over the last few years. Traditional and anecdotal use of marijuana for gastrointestinal disorders, such as diarrhoea and abdominal cramps is recognized, but the therapeutic benefit of cannabinoids in the 21st century is overshadowed by the psychoactive problems associated with CB 1 receptor activation. However, the presence and function of the CB 2 receptor in the GI tract, whilst not yet well characterized, holds great promise due to its immunomodulatory roles in inflammatory systems and its lack of psychotropic effects. This review of our current knowledge of CB 2 receptors in the gastrointestinal tract highlights its role in regulating abnormal motility, modulating intestinal inflammation and limiting visceral sensitivity and pain. CB 2 receptors represent a braking system and a pathophysiological mechanism for the resolution of inflammation and many of its symptoms. CB 2 receptor activation therefore represents a very promising therapeutic target in gastrointestinal inflammatory states where there is immune activation and motility dysfunction. British Journal of Pharmacology (2008) 153, 263–270; doi:10.1038/sj.bjp.0707486; published online 1 October 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammatory bowel disease: cause and immunobiology
Baumgart, D. C., & Carding, S. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60750-8 · Cited by 2,147
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470
Self-citationItzkowitz, S. H., & Yio, X. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00079.2004 · Cited by 1,274
The endocannabinoid system and its therapeutic exploitation
Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090
Inflammation, a Key Event in Cancer Development
Lu, H., Ouyang, W., & Huang, C. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0261 · Cited by 1,028
Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., Dubuquoy, C., Merour, E., Geboes, K., Chamaillard, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1521 · Cited by 793
Cannabinoid-based drugs as anti-inflammatory therapeutics
Klein, T. W. (2005) · Nature Reviews Immunology · doi:10.1038/nri1602 · Cited by 728
HU-308: A specific agonist for CB 2 , a peripheral cannabinoid receptor
Hanuš, L., Breuer, A., Tchilibon, S., Shiloah, S., Goldenberg, D., Horowitz, M., Pertwee, R. G., Ross, R. A., Mechoulam, R., & Fride, E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14228 · Cited by 571
Antifibrogenic role of the cannabinoid receptor CB2 in the liver
Julien, B., Grenard, P., Teixeira-Clerc, F., Van Nhieu, J. T., Li, L., Karsak, M., Zimmer, A., Mallat, A., & Lotersztajn, S. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.050 · Cited by 470
Elson, C. O., Cong, Y., McCracken, V. J., Dimmitt, R. A., Lorenz, R. G., & Weaver, C. T. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00291.x · Cited by 469
The endogenous cannabinoid system protects against colonic inflammation
Massa, F., Marsicano, G., Hermann, H., Cannich, A., Monory, K., Cravatt, B. F., Ferri, G.-L., Sibaev, A., Storr, M., & Lutz, B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19465 · Cited by 460
Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice
Verdú, E. F., Bercik, P., Verma-Gandhu, M., Huang, X.-X., Blennerhassett, P., Jackson, W., Mao, Y., Wang, L., Rochat, F., & Collins, S. M. (2006) · Gut · doi:10.1136/gut.2005.066100 · Cited by 448
Ulcerative colitis and adenocarcinoma of the colon in Gαi2-deficient mice
Rudolph, U., Finegold, M. J., Rich, S. S., Harriman, G. R., Srinivasan, Y., Brabet, P., Boulay, G., Bradley, A., & Birnbaumer, L. (1995) · Nature Genetics · doi:10.1038/ng0695-143 · Cited by 410
Ross, R. A., Brockie, H. C., Stevenson, L. A., Murphy, V. L., Templeton, F., Makriyannis, A., & Pertwee, R. G. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702351 · Cited by 404
Cannabinoid CB2 receptor: a new target for controlling neural cell survival?
Fernández-Ruiz, J., Romero, J., Velasco, G., Tolón, R. M., Ramos, J. A., & Guzmán, M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.11.001 · Cited by 362
Mechanisms of hypersensitivity in IBS and functional disorders
Azpiroz, F., Bouin, M., Camilleri, M., Mayer, E. A., Poitras, P., Serra, J., & Spiller, R. C. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00875.x · Cited by 354
Cannabinoids and the gastrointestinal tract
PERTWEE, R. G. (2001) · Gut · doi:10.1136/gut.48.6.859 · Cited by 326
Farrokhyar, F., Marshall, J. K., Easterbrook, B., & Irvine, J. E. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000195391.49762.89 · Cited by 310 · cited 3×
“from this condition (Farrokhyar et al., 2006). Pain is also one Received 13 July 2007; revised 15 August 2007; accepted 5 September 2007; published online 1 October 2007 Correspondence: Dr KA Sharkey, Department of Physiology and Biophysics, University of Calgary, 3330 Hospital Drive N.W., Calgary, Alberta, Canada, T2…”
BackgroundII. The intestine as a sensory organ: neural, endocrine, and immune responses
Furness, J. B., Kunze, W. A. A., & Clerc, N. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.277.5.g922 · Cited by 300
WRIGHT, K., ROONEY, N., FEENEY, M., TATE, J., ROBERTSON, D., WELHAM, M., & WARD, S. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.026 · Cited by 299
Self-citationPossible endocannabinoid control of colorectal cancer growth
Ligresti, A., Bisogno, T., Matias, I., De Petrocellis, L., Cascio, M. G., Cosenza, V., D’argenio, G., Scaglione, G., Bifulco, M., Sorrentini, I., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00881-3 · Cited by 287
Sensory transmission in the gastrointestinal tract
Blackshaw, L. A., Brookes, S. J. H., Grundy, D., & Schemann, M. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00871.x · Cited by 286
Fibrogenesis in Crohn's Disease
Burke, J. P., Mulsow, J. J., O'Keane, C., Docherty, N. G., Watson, R. W. G., & O'Connell, P. R. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.01010.x · Cited by 279
Izzo, A. A., Fezza, F., Capasso, R., Bisogno, T., Pinto, L., Iuvone, T., Esposito, G., Mascolo, N., Di Marzo, V., & Capasso, F. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704293 · Cited by 256
D'Argenio, G., Valenti, M., Scaglione, G., Cosenza, V., Sorrentini, I., & Di Marzo, V. (2006) · The FASEB Journal · doi:10.1096/fj.05-4943fje · Cited by 222
Enteric neuroplasticity evoked by inflammation
Vasina, V., Barbara, G., Talamonti, L., Stanghellini, V., Corinaldesi, R., Tonini, M., De Ponti, F., & De Giorgio, R. (2006) · Autonomic Neuroscience · doi:10.1016/j.autneu.2006.02.025 · Cited by 221
Greenhough, A., Patsos, H. A., Williams, A. C., & Paraskeva, C. (2007) · International Journal of Cancer · doi:10.1002/ijc.22917 · Cited by 182
Endocannabinoids as physiological regulators of colonic propulsion in mice
Pinto, L., Izzo, A. A., Mascolo, N., Capasso, F., Cascio, M. G., Bisogno, T., Di Marzo, V., Hospodar–Scott, K., & Brown, D. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.34242 · Cited by 180
Review article: endocannabinoids and their receptors in the enteric nervous system
Duncan, M., Davison, J. S., & Sharkey, K. A. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02648.x · Cited by 174
Self-citationKimball, E. S., Schneider, C. R., Wallace, N. H., & Hornby, P. J. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00407.2005 · Cited by 172
Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals
Griffin, G., Fernando, S. R., Ross, R. A., McKay, N. G., Ashford, M. L. J., Shire, D., Huffman, J. W., Yu, S., Lainton, J. A. H., & Pertwee, R. G. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01336-8 · Cited by 171
The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract
Massa, F., Storr, M., & Lutz, B. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0698-5 · Cited by 146
Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes
Joseph, J., Niggemann, B., Zaenker, K. S., & Entschladen, F. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0509-9 · Cited by 145
Mathison, R., Ho, W., Pittman, Q. J., Davison, J. S., & Sharkey, K. A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705889 · Cited by 144
Self-citationCannabinoids for gastrointestinal diseases: potential therapeutic applications
Carlo, G. D., & Izzo, A. A. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.1.39 · Cited by 136
An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice
Izzo, A. A., Capasso, F., Costagliola, A., Bisogno, T., Marsicano, G., Ligresti, A., Matias, I., Capasso, R., Pinto, L., Borrelli, F., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00892-8 · Cited by 132
Cabral, G. A., & Staab, A. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-26573-2_13 · Cited by 130
The endocannabinoid system and gut–brain signalling
Storr, M., & Sharkey, K. A. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.08.008 · Cited by 130
Self-citationInvolvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats
Sanson, M., Bueno, L. P., & Fioramonti, J. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00819.x · Cited by 121
The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats
Izzo, A. A., Mascolo, N., Pinto, L., Capasso, R., & Capasso, F. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00673-1 · Cited by 115
Endocannabinoid overactivity and intestinal inflammation
Marzo, V. D., & Izzo, A. A. (2006) · Gut · doi:10.1136/gut.2005.090472 · Cited by 114
Cannabinoids Ameliorate Pain and Reduce Disease Pathology in Cerulein-Induced Acute Pancreatitis
Michalski, C. W., Laukert, T., Sauliunaite, D., Pacher, P., Bergmann, F., Agarwal, N. K., Su, Y. Y., Giese, T., Giese, N. A., Bátkai, S., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.035 · Cited by 112
Esfandyari, T., Camilleri, M., Busciglio, I. A., Burton, D. D., Baxter, K. L., & Zinsmeister, A. R. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00565.2006 · Cited by 112
Involvement of cannabinoid receptors in gut motility and visceral perception
Hornby, P. J., & Prouty, S. M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705783 · Cited by 103
The endocannabinoid system and the molecular basis of paralytic ileus in mice
Mascolo, N., Izzo, A. A., Ligresti, A., Costagliola, A., Pinto, L., Cascio, M. G., Maffia, P., Cecio, A., Capasso, F., & Marzo, V. D. (2002) · The FASEB Journal · doi:10.1096/fj.02-0338fje · Cited by 99
Formation of B and T cell subsets require the cannabinoid receptor CB2
Ziring, D., Wei, B., Velázquez, P., Schrage, M. I., Buckley, N. E., & Braun, J. G. (2006) · Immunogenetics · doi:10.1007/s00251-006-0138-x · Cited by 98
Patsos, H. A., Hicks, D. J., Dobson, R. R. H., Greenhough, A., Woodman, N., Lane, J. D., Williams, A. C., & Paraskeva, C. (2005) · Gut · doi:10.1136/gut.2005.073403 · Cited by 98
Cannabinoids and the Digestive Tract
Izzo, A. A., & Coutts, A. A. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_19 · Cited by 91
Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids
Ihenetu, K., Molleman, A., Parsons, M. E., & Whelan, C. J. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02698-5 · Cited by 76
Effect of cannabinoids on neural transmission in rat gastric fundus
Storr, M., Gaffal, E., Saur, D., SCHUSDZIARRA, V., & Allescher, H. D. (2002) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y02-005 · Cited by 74
Targeting the CB2receptor for immune modulation
Lunn, C. A., Reich, E., & Bober, L. A. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.5.653 · Cited by 68
Guagnini, F., Valenti, M., Mukenge, S., Matias, I., Bianchetti, A., Palo, S. D., Ferla, G., Marzo, V. D., & Croci, T. (2006) · Gut · doi:10.1136/gut.2005.076372 · Cited by 68
Anandamides: tolerance and cross-tolerance toΔ9-tetrahydrocannabinol
Fride, E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00790-w · Cited by 67
D’Argenio, G., Petrosino, S., Gianfrani, C., Valenti, M., Scaglione, G., Grandone, I., Nigam, S., Sorrentini, I., Mazzarella, G., & Marzo, V. D. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0192-3 · Cited by 67
Modulation of peristalsis by cannabinoid CB1 ligands in the isolated guinea‐pig ileum
Izzo, A. A., Mascolo, N., Tonini, M., & Capasso, F. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703116 · Cited by 63
Autocrine and Paracrine Regulation of Lymphocyte CB2 Receptor Expression by TGF-β
Gardner, B. K., Zu, L. X., Sharma, S. P., Liu, Q., Makriyannis, A., Tashkin, D. P., & Dubinett, S. M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6179 · Cited by 59
Activation of the cannabinoid 2 (CB2) receptor inhibits murine mesenteric afferent nerve activity
Hillsley, K., Mccaul, C., Aerssens, J., Peeters, P. J., Gijsen, H. J. M., Moechars, D., Coulie, B. J., Grundy, D., & Stead, R. H. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.00950.x · Cited by 45
Cannabinoids cool the intestine
Kunos, G., & Pacher, P. (2004) · Nature Medicine · doi:10.1038/nm0704-678 · Cited by 37
Cited by
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Pertwee, R. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00048.x · Cited by 436
Cannabinoids and the gut: New developments and emerging concepts
Izzo, A. A., & Sharkey, K. A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.12.005 · Cited by 419
Self-citationIs lipid signaling through cannabinoid 2 receptors part of a protective system?
Pacher, P., & Mechoulam, R. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.01.001 · Cited by 414
Modulating the endocannabinoid system in human health and disease – successes and failures
Pacher, P., & Kunos, G. (2013) · The FEBS Journal · doi:10.1111/febs.12260 · Cited by 405
Early phytocannabinoid chemistry to endocannabinoids and beyond
Mechoulam, R., Hanuš, L. O., Pertwee, R., & Howlett, A. C. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3811 · Cited by 393
Metadata
- Authors
- Wright, K. L., Duncan, M., & Sharkey, K. A.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2008-01
- Volume
- 153
- Issue
- 2
- Pages
- 263-270
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1964856587
- Cited by
- 264
- References
- 59
- FWCI
- 9.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.